Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks.

confounding control data-sharing disease risk score distributed data networks meta-analysis multicenter studies privacy protection propensity score

Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 05 04 2018
revised: 29 11 2018
accepted: 03 12 2018
pubmed: 12 12 2018
medline: 25 12 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Distributed data networks enable large-scale epidemiologic studies, but protecting privacy while adequately adjusting for a large number of covariates continues to pose methodological challenges. Using 2 empirical examples within a 3-site distributed data network, we tested combinations of 3 aggregate-level data-sharing approaches (risk-set, summary-table, and effect-estimate), 4 confounding adjustment methods (matching, stratification, inverse probability weighting, and matching weighting), and 2 summary scores (propensity score and disease risk score) for binary and time-to-event outcomes. We assessed the performance of combinations of these data-sharing and adjustment methods by comparing their results with results from the corresponding pooled individual-level data analysis (reference analysis). For both types of outcomes, the method combinations examined yielded results identical or comparable to the reference results in most scenarios. Within each data-sharing approach, comparability between aggregate- and individual-level data analysis depended on adjustment method; for example, risk-set data-sharing with matched or stratified analysis of summary scores produced identical results, while weighted analysis showed some discrepancies. Across the adjustment methods examined, risk-set data-sharing generally performed better, while summary-table and effect-estimate data-sharing more often produced discrepancies in settings with rare outcomes and small sample sizes. Valid multivariable-adjusted analysis can be performed in distributed data networks without sharing of individual-level data.

Identifiants

pubmed: 30535131
pii: 5233451
doi: 10.1093/aje/kwy265
pmc: PMC6438804
mid: NIHMS1002303
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

709-723

Subventions

Organisme : Patient-Centered Outcomes Research Institute
ID : ME-1403-11305
Pays : United States
Organisme : AHRQ HHS
ID : R01 HS026214
Pays : United States
Organisme : NIBIB NIH HHS
ID : U01 EB023683
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Clin Pharmacol Ther. 2011 Dec;90(6):883-7
pubmed: 22030567
Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1034-1041
pubmed: 30022561
Health Aff (Millwood). 2014 Jul;33(7):1178-86
pubmed: 25006144
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:282-90
pubmed: 22262618
Int J Biostat. 2013 Jul 31;9(2):215-34
pubmed: 23902694
JAMA. 2011 Dec 7;306(21):2331-9
pubmed: 22056398
Med Care. 2014 Jul;52(7):664-8
pubmed: 24926715
Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):848-57
pubmed: 20162632
Arthritis Res Ther. 2011;13(5):R155
pubmed: 21933396
JAMA Surg. 2016 Nov 1;151(11):1046-1055
pubmed: 27579793
Epidemiology. 2009 Jul;20(4):512-22
pubmed: 19487948
Am J Epidemiol. 2011 Sep 1;174(5):613-20
pubmed: 21749976
N Engl J Med. 2011 Feb 10;364(6):498-9
pubmed: 21226658
J Am Med Inform Assoc. 2012 Sep-Oct;19(5):758-64
pubmed: 22511014
Med Care. 2010 Jun;48(6 Suppl):S45-51
pubmed: 20473204
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Pharmacoepidemiol Drug Saf. 2012 May;21(5):524-34
pubmed: 22411435
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1171-7
pubmed: 23878013
Ann Intern Med. 2009 Sep 1;151(5):341-4
pubmed: 19638403
Value Health. 2010 Mar-Apr;13(2):273-7
pubmed: 19912596
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1205-13
pubmed: 24038742
N Engl J Med. 2009 Jul 30;361(5):445-54
pubmed: 19641201
Epidemiology. 2017 May;28(3):387-395
pubmed: 28151746
J Comp Eff Res. 2017 Sep;6(6):537-547
pubmed: 28805448
Clin Epidemiol. 2018 Nov 27;10:1773-1786
pubmed: 30568510
Arthritis Rheum. 2007 Apr;56(4):1125-33
pubmed: 17393394
EGEMS (Wash DC). 2018 May 25;6(1):11
pubmed: 30094283
Arch Intern Med. 2012 Nov 12;172(20):1582-9
pubmed: 23147456
JAMA Surg. 2014 Dec;149(12):1279-87
pubmed: 25353723
J Clin Epidemiol. 1989;42(4):317-24
pubmed: 2723692
Am J Epidemiol. 2009 Sep 1;170(5):650-6
pubmed: 19625341
Med Care. 2013 Aug;51(8 Suppl 3):S4-10
pubmed: 23752258

Auteurs

Xiaojuan Li (X)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Bruce H Fireman (BH)

Division of Research, Kaiser Permanente Northern California, Oakland, California.

Jeffrey R Curtis (JR)

Division of Clinical Immunology and Rheumatology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

David E Arterburn (DE)

Kaiser Permanente Washington Health Research Institute, Seattle, Washington.

David P Fisher (DP)

The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, California.

Érick Moyneur (É)

StatLog Econometrics Inc., Montreal, Quebec, Canada.

Mia Gallagher (M)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Marsha A Raebel (MA)

Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.

W Benjamin Nowell (WB)

CreakyJoints, Global Healthy Living Foundation, Upper Nyack, New York.

Lindsay Lagreid (L)

Limeade, Bellevue, Washington.

Sengwee Toh (S)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH